jeudi 4 juin 2020

Onco Actu du 4 juin 2020


1. BIOLOGIE



‘Terminator’ protein halts cancer-causing cellular processes [Cornell]











2.9 ETIOLOGIE - TABAC



Cancer risk for non-daily smokers 4 times higher than non-smokers [UPI]










4.5 DÉP., DIAG. & PRONO. - COLORECTAL



How a Delay in Colonoscopy Screening May Affect Cancer Risk [NY Times]










5. TRAITEMENTS



New method of manufacturing targeted drugs could lead to better cancer treatments [USC]











5.2.1 PHARMA - PARTENARIATS



AstraZeneca to discover and develop novel therapies targeting RNA-modifying proteins in oncology collaboration with Accent Therapeutics [AstraZeneca]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



BeiGene Announces the Approval of BRUKINSA™ (Zanubrutinib) in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell Lymphoma [BeiGene]











EMA Recommends Extension of Indications for Olaparib [ESMO]











5.5.4.5 ASCO (IMMUNOTHÉRAPIES-CAR-T, THÉRAPIES CELLULAIRES)



Durable Remission, Rare Adverse Effects With Anti-CD19 CAR-T Therapy in CLL, Lymphoma [Oncology Times]











6.1 OBSERVATION



Study Puts Price Tag on Lost Earnings from Racial Disparities in Cancer Mortality [ACS]